Form 8-K Adaptive Biotechnologies For: Jun 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Adaptive Biotechnologies issues $345M in convertible notes due 2031
June 22, 2026 4:10 PM EDTAdaptive Biotechnologies Corp. (NASDAQ: ADPT) issued $345 million in aggregate principal amount of 0% Convertible Senior Notes due 2031, according to a company statement.
The notes, issued on June 22, 2026, include the full exercise by initial purchasers of an option to purchase an additional $45 million in... More
